Cargando…

Treatment of Patients with Monoclonal Gammopathy of Clinical Significance

SIMPLE SUMMARY: Monoclonal gammopathy of clinical significance (MGCS) is a recently recognized clinical-pathological entity. Symptoms are caused by the presence of a monoclonal protein leading to high comorbidity. The affected organs vary according to the target antigen However, as most of the knowl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno, David F., Rosiñol, Laura, Cibeira, María Teresa, Bladé, Joan, Fernández de Larrea, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533809/ https://www.ncbi.nlm.nih.gov/pubmed/34680279 http://dx.doi.org/10.3390/cancers13205131

Ejemplares similares

Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy
por: Moreno, David F., et al.
Publicado: (2021)

MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE
por: Bladé, J.
Publicado: (2023)

Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia
por: Moreno, David F., et al.
Publicado: (2022)

Monoclonal gammopathy of undetermined significance: a contraindication for living kidney donation?
por: Serra, Nuria, et al.
Publicado: (2011)

The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
por: Castillo, Jorge J., et al.
Publicado: (2021)

Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution
por: Jiménez-Segura, Raquel, et al.
Publicado: (2022)

Monoclonal Gammopathy of Thrombotic Significance
por: Gkalea, Vasiliki, et al.
Publicado: (2023)

Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution
por: Rodríguez-Lobato, Luis Gerardo, et al.
Publicado: (2023)

Diagnosis and management of monoclonal gammopathy of clinical significance
por: Cho, Hyungwoo
Publicado: (2022)

Monoclonal Gammopathies of Clinical Significance: A Critical Appraisal
por: Ríos-Tamayo, Rafael, et al.
Publicado: (2022)

From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance
por: Visentin, Andrea, et al.
Publicado: (2022)

A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma
por: Navarro, Alfons, et al.
Publicado: (2015)

Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
por: Girard, Louis-Pierre, et al.
Publicado: (2022)

Monoclonal gammopathy of “ocular” significance
por: Karakus, Sezen, et al.
Publicado: (2019)

Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
por: Aslam, Nabeel, et al.
Publicado: (2021)

Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond
por: Menè, Paolo, et al.
Publicado: (2020)

Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies
por: Innao, Vanessa, et al.
Publicado: (2021)

Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment
por: Oganesyan, Artem, et al.
Publicado: (2022)

IgM monoclonal gammopathies of clinical significance: diagnosis and management
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

A Fresh Perspective on Monoclonal Gammopathies of Renal Significance
por: Aucouturier, Pierre, et al.
Publicado: (2021)

The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance
por: Mehtat Ünlü, Şadiye, et al.
Publicado: (2017)

Monoclonal gammopathy of renal significance: case report
por: Fonseca, Gabriela Spacek da, et al.
Publicado: (2018)

Evidence for immunoglobulin-mediated vasculitis caused by monoclonal gammopathy in monoclonal gammopathy of unclear significance prompting oncologic treatment
por: Drerup, Christian, et al.
Publicado: (2019)

Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance
por: Lee, Holly, et al.
Publicado: (2019)

Editorial: Monoclonal gammopathies of clinical significance: Clinical and therapeutic implications
por: Wang, Chen, et al.
Publicado: (2023)

Advances in the understanding of IgM monoclonal gammopathy of undetermined significance
por: Paludo, Jonas, et al.
Publicado: (2017)

Characterization of Monoclonal Gammopathy of Undetermined Significance by Calorimetric Analysis of Blood Serum Proteome
por: Barceló, Francisca, et al.
Publicado: (2015)

Immunophenotypic studies of monoclonal gammopathy of undetermined significance
por: Olteanu, Horatiu, et al.
Publicado: (2008)

Monoclonal Gammopathy of Undetermined Significance-associated Scleromyxoedema
por: Baxi, Kalgi D., et al.
Publicado: (2019)

Monoclonal gammopathy of renal significance: Diagnostic workup
por: Correia, Sofia O, et al.
Publicado: (2017)

Monoclonal gammopathy of increasing significance: time to screen?
por: Chen, Lucia Y., et al.
Publicado: (2022)

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
por: Leung, Nelson, et al.
Publicado: (2018)

Cutaneous manifestations of monoclonal gammopathy
por: Claveau, Jean-Sebastien, et al.
Publicado: (2022)

Monoclonal gammopathies
por: Tozzi, S
Publicado: (2010)

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
por: Lomas, Oliver C., et al.
Publicado: (2020)

Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma
por: Tomasson, Michael H., et al.
Publicado: (2018)

Crystalloid glomerulopathy in monoclonal gammopathy of renal significance (MGRS)
por: Vankalakunti, Mahesha, et al.
Publicado: (2014)

Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
por: Steiner, Normann, et al.
Publicado: (2016)

Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
por: Sigurbergsdóttir, Aðalbjörg Ýr, et al.
Publicado: (2022)

Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
por: Lyle, Melissa A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ecqulbbhm5ehhmueh51hgc1p4k